1
![Oncodesign]()
![Oncodesign]()
![Oncodesign]()
Oncodesign
Leadership team
Philippe Genne (Founder)
Products/ Services
Biotechnology, Health Care, Therapeutics
Number of Employees
100 - 500
Headquarters
Dijon, Bourgogne, France
Established
1995
Traded as
EPA:AlONC
Overview
Location
Summary
Oncodesign is a biotech company developing innovative therapies to target proteins that are involved in cancer. We are specialized in small molecule drugs and studying the molecular mechanisms of cancer. Our teams work in close partnership with the leading academic and clinical institutions across the world.
History
Oncodesign was established in 2006 and developed its innovative technology platform. Since then, the company has grown rapidly, with offices in many countries and partnerships worldwide. We have extended our research and clinical portfolio and today, Oncodesign offers an innovative pipeline of cancer treatments and protein-targeting capabilities.
Mission
Our mission is to develop treatments for cancer by identifying and targeting key proteins involved in the disease. We leverage cutting-edge technology to offer tailor-made solutions that can improve patient outcomes, reduce the cost and increase access to care.
Vision
Our vision is to be a leading biotech company in cancer research and therapy, providing safe, effective and affordable therapies for any cancer patient.
Key Team
Philippe Genne (Founder)
Recognition and Awards
Oncodesign has been repeatedly recognized with awards and distinctions, such as the Prix Léopold Sedar Senghor, Prix EcoBio and Eureka Prize. As a testament to our contributions to cancer therapy, we have been chosen as finalists for the Nobel Prize in Medicine in 2015.
References
Dive deeper into fresh insights across Business, Industry Leaders and Influencers, Organizations, Education, and Investors for a comprehensive view.
Leadership team
Philippe Genne (Founder)
Products/ Services
Biotechnology, Health Care, Therapeutics
Number of Employees
100 - 500
Headquarters
Dijon, Bourgogne, France
Established
1995
Traded as
EPA:AlONC